journal articleLitStream CollectionPublic information, private money1998 Nature Biotechnologydoi: 10.1038/nbt0698-491apmid: N/A
journal articleLitStream CollectionKeep the story straight1998 Nature Biotechnologydoi: 10.1038/nbt0698-491bpmid: N/A
journal articleLitStream CollectionWhy pharmacogenomics? Why now?Housman, David; Ledley, Fred D.1998 Nature Biotechnologydoi: 10.1038/nbt0698-492pmid: 9624664
journal articleLitStream CollectionTransferring EU-funded biotechnology research to European bioindustryLawler, Colm; van der Meer, Robert; Viseur, Jacques1998 Nature Biotechnologydoi: 10.1038/nbt0698-494pmid: 9624665
journal articleLitStream CollectionDo corporate gifts compromise biotech researchers?Hoyle, Russ1998 Nature Biotechnologydoi: 10.1038/nbt0698-495pmid: 9624666
journal articleLitStream CollectionGene therapy or antisenseTomasi, Vittorio1998 Nature Biotechnologydoi: 10.1038/nbt0698-496cpmid: 9624669
journal articleLitStream CollectiondeCODE deferredEyfjörd, Jorunn Erla; Ögmundsdottir, Helga M.; Zoëga, Tomas1998 Nature Biotechnologydoi: 10.1038/nbt0698-496apmid: 9624667
journal articleLitStream CollectionUnfair treatmentFowlkes, John1998 Nature Biotechnologydoi: 10.1038/nbt0698-496bpmid: 9624668
journal articleLitStream CollectionBusiness and Regulatory News1998 Nature Biotechnologydoi: 10.1038/nbt0698-497pmid: N/A
journal articleLitStream CollectionResearch News1998 Nature Biotechnologydoi: 10.1038/nbt0698-500pmid: N/A